This recording is from the second session of Xstrahl's 2021 clinical symposia, Radiotherapy for Benign Conditions. https://vimeo.com/710916275
Radiotherapy for Hyperproliferative Disorders
read more
Resource Type
Radiotherapy for Benign Skin Conditions
This recording is from the third session of Xstrahl's 2021 clinical symposia, Radiotherapy for Benign Conditions. https://vimeo.com/711325664
Radiotherapy for Inflammatory Conditions
This recording is from the first session of Xstrahl's 2021 clinical symposia, Radiotherapy for Benign Conditions. https://vimeo.com/710910255
Radiotherapy for Benign Disease: Assessing the Risk of Radiation-Induced Cancer
Low Dose Radiation Therapy for COVID-19: Effective Dose and Estimation of Cancer Risk
Cancer Risk after Radiotherapy for Benign Diseases
SARRP used in Combination Therapy Tumor Suppression
The below graphic displays highlights from the study, "Synergistic Anticancer Activity of N-Hydroxy-7-(2-Naphthylthio Heptanomide, Sorafenib, and Radiation Therapy in Patient-Derived Anaplastic Thyroid Cancer Models" by HJ Yun, HJ Kim, J Kim, SY Kim, HS Chang, CS...
SARRP Enables Targeted Focal Irradiation
This data comes from the presentation, "Radiation Enhances Anti-Tumor Activity of Checkpoint Blockade in Syngeneic Tumor Models" by Covance researchers Sumithra Urs, Mary Anne Meade, Kevin Guley, Sarah Krueger, Alden Wong, Scott Wise, and Maryland Rosenfeld Franklin....
Preclinical Dosimetry in Radiation Research
Precise, consistent dosimetry is crucial for accurate, repeatable research. Here at Xstrahl, we strive to offer researchers all of the tools and support you need to ensure accurate radiation dosage. Learn how we are doing that with our research systems and support...
Contact Us